Alexander T. Yarbrough

Alex advises companies and other market participants on capital markets transactions, commercial contracts, and mergers and acquisitions. He represents issuers and underwriters in a variety of securities offerings, including initial public offerings, follow-on public offerings, Rule 144A offerings, as well as private placements (including PIPE transactions). Alex also counsels issuers with regard to their ongoing reporting obligations under the Securities Exchange Act of 1934, as well as Nasdaq, NYSE, and other exchange listing and compliance matters.

• Represented a contract development and manufacturing organization (CDMO) in concurrent public offerings with gross proceeds of $35.6 million.
• Represented a biopharmaceutical company in its $45.2 million initial public offering.
• Represented an underwriter in connection with a $75 million bought deal public offering of common stock.
• Represented a biotechnology company in its initial public offering and subsequent follow-on offering, totaling approximately $20.6 million.
• Represented a specialty health sciences company in its follow-on public offerings totaling $14.2 million and “at-the-market offerings,” totaling $35 million.
• Represented an artificial intelligence driven platform provider and course designer in its initial public offering of $15 million.
• Represented a German-based company in its €30 million Rule 144A offering of ordinary bearer shares in the U.S.

• Best Lawyers in America®: Ones to Watch: Life Sciences Practice (2024-2026)